文献速递产科

需要高剂量缩宫素的分娩妇女中存在新型缩宫素受体变异

Novel oxytocin receptor variants in laboring women requiring high doses of oxytocin.
PubMed 文献 · Am J Obstet Gynecol · 2017-04-26

该研究对足月初产妇按缩宫素用量≤4 mU/min(低剂量组,n=83)或≥20 mU/min(高剂量组,n=104)分组,进行缩宫素受体基因编码外显子靶向测序。高剂量组肥胖、糖尿病、引产及使用前列腺素比例更高;两组间缩宫素受体变异频率无显著差异,但新型变异在高剂量组中富集,其中R150L、R151C和H173R被预测损害受体功能。

要点

  • 高剂量缩宫素需求与肥胖、糖尿病和引产相关。
  • 两组间缩宫素受体变异频率无显著差异,但新型变异在高剂量组富集。
  • R150L、R151C和H173R被预测损害缩宫素受体功能。

核心结论

  • 肥胖、糖尿病和引产与需要高剂量缩宫素相关。
  • 低剂量需求组与高剂量需求组之间缩宫素受体变异频率无显著差异,但新型缩宫素受体变异在高剂量需求组中富集。
  • 发现3个缩宫素受体变异(2个新型、1个已知)被预测损害缩宫素受体功能,可能增加个体需要高剂量缩宫素的风险。
  • 需进一步研究缩宫素受体变异及其对蛋白功能的影响,以指导孕妇精准医学。

研究设计与样本

  • 足月、未产妇女因引产或加强宫缩需要缩宫素剂量≤4 mU/min(低剂量需求组,n=83)或≥20 mU/min(高剂量需求组,n=104)者签署知情同意,产后采血提取基因组DNA。
  • 采用MiSeq(Illumina)进行靶向扩增子测序(覆盖度>30×),检测缩宫素受体基因编码外显子变异。
  • 比较两组基线临床病史、结局、人口学特征及缩宫素受体基因序列变异和等位基因频率。
  • 使用尺度不变特征变换算法预测变异对缩宫素受体功能的影响。
  • 分类变量采用Fisher精确检验或χ2检验,连续变量采用Student t检验或Wilcoxon秩和检验,P值<0.05认为有统计学意义。

主要发现

  • 高剂量需求组肥胖和糖尿病率更高,更可能接受引产并使用前列腺素。
  • 高剂量需求组更可能因第一产程停滞行剖宫产,因胎儿状态不可靠行剖宫产更少。
  • 全队列(n=187)靶向测序发现30个不同的编码变异:17个非同义、11个同义和2个小结构变异。
  • 新型变异A243T在低剂量和高剂量需求组均发现;3个新型变异(Y106H、A240_A249del和P197delfs*206)仅见于低剂量需求组。
  • 9个非同义变异为高剂量需求组独有,包括3个已知变异(R151C、G221S和W228C)和6个新型变异(M133V、R150L、H173R、A248V、G253R和I266V);其中R150L、R151C和H173R被尺度不变特征变换算法预测损害缩宫素受体功能。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although oxytocin commonly is used to augment or induce labor, it is difficult to predict its effectiveness because oxytocin dose requirements vary significantly among women. One possibility is that women requiring high or low doses of oxytocin have variations in the oxytocin receptor gene. OBJECTIVES: To identify oxytocin receptor gene variants in laboring women with low and high oxytocin dosage requirements. STUDY DESIGN: Term, nulliparous women requiring oxytocin doses of ≤4 mU/min (low-dose-requiring, n = 83) or ≥20 mU/min (high-dose-requiring, n = 104) for labor augmentation or induction provided consent to a postpartum blood draw as a source of genomic DNA. Targeted-amplicon sequencing (coverage >30×) with MiSeq (Illumina) was performed to discover variants in the coding exons of the oxytocin receptor gene. Baseline relevant clinical history, outcomes, demographics, and oxytocin receptor gene sequence variants and their allele frequencies were compared between low-dose-requiring and high-dose-requiring women. The Scale-Invariant Feature Transform algorithm was used to predict the effect of variants on oxytocin receptor function. The Fisher exact or χ2 tests were used for categorical variables, and Student t tests or Wilcoxon rank sum tests were used for continuous variables. A P value < .05 was considered statistically significant. RESULTS: The high-dose-requiring women had greater rates of obesity and diabetes and were more likely to have undergone labor induction and required prostaglandins. High-dose-requiring women were more likely to undergo cesarean delivery for first-stage arrest and less likely to undergo cesarean delivery for nonreassuring fetal status. Targeted sequencing of the oxytocin receptor gene in the total cohort (n = 187) revealed 30 distinct coding variants: 17 nonsynonymous, 11 synonymous, and 2 small structural variants. One novel variant (A243T) was found in both the low- and high-dose-requiring groups. Three novel variants (Y106H, A240_A249del, and P197delfs*206) resulting in an amino acid substitution, loss of 9 amino acids, and a frameshift stop mutation, respectively, were identified only in low-dose-requiring women. Nine nonsynonymous variants were unique to the high-dose-requiring group. These included 3 known variants (R151C, G221S, and W228C) and 6 novel variants (M133V, R150L, H173R, A248V, G253R, and I266V). Of these, R150L, R151C, and H173R were predicted by Scale-Invariant Feature Transform algorithm to damage oxytocin receptor function. There was no statistically significant association between the numbers of synonymous and nonsynonymous substitutions in the patient groups. CONCLUSION: Obesity, diabetes, and labor induction were associated with the requirement for high doses of oxytocin. We did not identify significant differences in the prevalence of oxytocin receptor variants between low-dose-requiring and high-dose-requiring women, but novel oxytocin receptor variants were enriched in the high-dose-requiring women. We also found 3 oxytocin receptor variants (2 novel, 1 known) that were predicted to damage oxytocin receptor function and would likely increase an individual's risk for requiring a high oxytocin dose. Further investigation of oxytocin receptor variants and their effects on protein function will inform precision medicine in pregnant women.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Reinl EL, Goodwin ZA, Raghuraman N, et al. Novel oxytocin receptor variants in laboring women requiring high doses of oxytocin. Am J Obstet Gynecol. 2017. PMID: 28456503. doi:10.1016/j.ajog.2017.04.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。